title: Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.
abstract: The secretions of interleukin 1 (IL-1), tumour necrosis factor alpha (TNF), and prostaglandin E2 (PGE2) of low-dose E. coli lipopolysaccharide (LPS)-stimulated human monocytes (M phi) were investigated in an endotoxin (ET)-free milieu (less than 1.6 pg LPS/ml). Human M phi cultures from nine healthy men were stimulated with 0, 12.5-500, and 250,000 pg LPS/ml as measured by a very sensitive Limulus test. The IL-1 activity was tested by the mouse costimulatory thymocyte (LAF) assay, which was thoroughly standardized and characterized (interassay variation 22-24%, intra-assay variation 3-7%). Spontaneous M phi secretions of IL-1, TNF, and PGE2 were negligible, but 12.5 pg LPS/ml significantly stimulated the secretions of these M phi products and the monokine responses to 500 and 250,000 pg LPS/ml were almost in the same range. It was demonstrated that the secretions of IL-1-TNF and TNF-PGE2 were strongly correlated. Pronounced interindividual differences in LPS responsiveness were demonstrated, and two low-responders, one of whom was HLA-DR1,2-positive, were identified. Three first-degree relatives of the DR1,2-positive low-responder had similar low responses. Furthermore, M phi cultures were prepared weekly for 4 weeks from four HLA-DR different men and the only DR2,2 homozygous individual had low monokine responses. In conclusion, stable interindividual differences in in vitro monokine and PGE2 secretions of LPS-stimulated M phi were demonstrated. It is suggested that HLA-DR2-positive individuals may be low responders.
authors.affiliation: Steno Memorial Hospital, Gentofte, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Mølvig
authors.forename: L
authors.initials: L
authors.lastname: Baek
authors.forename: P
authors.initials: P
authors.lastname: Christensen
authors.forename: K R
authors.initials: KR
authors.lastname: Manogue
authors.forename: H
authors.initials: H
authors.lastname: Vlassara
authors.forename: P
authors.initials: P
authors.lastname: Platz
authors.forename: L S
authors.initials: LS
authors.lastname: Nielsen
authors.forename: A
authors.initials: A
authors.lastname: Svejgaard
authors.forename: J
authors.initials: J
authors.lastname: Nerup
mesh_terms: D001688:Biological Products / Q000378:metabolism; D015232:Dinoprostone; D004305:Dose-Response Relationship, Drug; D004731:Endotoxins / Q000494:pharmacology*; D005260:Female; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000502:physiology*; D008297:Male; D009000:Monocytes / Q000502:physiology*; D015846:Monokines; D011458:Prostaglandins E / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D001688:Biological Products; D004731:Endotoxins; D006684:HLA-DR Antigens; D007375:Interleukin-1; D008070:Lipopolysaccharides; D015846:Monokines; D011458:Prostaglandins E; D014409:Tumor Necrosis Factor-alpha; D015232:Dinoprostone